# OLANZAPINE
> **ANDA202285** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2014-05-12
## Drug
- **FDA Application Number:** ANDA202285
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLANZAPINE
- **Generic name:** Olanzapine
- **Active ingredients:** OLANZAPINE
- **Dosage form:** TABLET, ORALLY DISINTEGRATING
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PHARMOBEDIENT
- **First approval:** 2014-05-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202285)
---
*MORVS · CC0 1.0*